Saturday, November 2, 2024
Home Tags Cannabinoids

cannabinoids Related News

cannabinoids

Scientists discover how cannabis cells produce cannabinoids

A team of plant biologists at The University of British Columbia has identified the process in which cannabis cells make cannabinoids for the first...
New data from UK Medical Cannabis Registry presented at symposium

New data from UK Medical Cannabis Registry presented at symposium

Sapphire Medical Clinics has presented new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on the...
Association for the Cannabinoid Industry to expand EU Offering

Association for the Cannabinoid Industry to expand EU Offering

The Association for the Cannabinoid Industry (ACI) has announced the opening of a new Brussels office as they expand their membership offering into the...
Taskforce proposes UK cannabinoid regulation changes

Taskforce proposes UK cannabinoid regulation changes

The Taskforce on Innovation, Growth and Regulatory Reform (TIGRR) has reported recommendations to the Prime Minister on how the UK can reshape regulation and...
Natural versus synthetic CBD

Natural versus synthetic CBD

Richard O’Halloran, CEO of Biosportart, discusses natural versus synthetic cannabidiol (CBD) compounds for use in products and what this means for the CBD industry. CBD...
Exploring the pharmacological and placebo effects of CBD for pain

Exploring the pharmacological and placebo effects of CBD for pain

A new study has shed light on the pain-reducing effects of CBD, as well as the impact that the placebo effect may have on...
Innovation and drug development with Tetra Bio-Pharma

Innovation and drug development with Tetra Bio-Pharma

Tetra Bio-Pharma executives speak out about building a cannabinoid pharmaceutical company. For this article, we sat down for a virtual fireside chat with some key...
Working towards fair, humanised policy on drugs with ENCOD

Working towards fair, humanised policy on drugs with ENCOD

MCN speaks to Maja Kohek of the European Coalition for Just and Effective Drug Policies about education, policy and harm reduction. The European Coalition for...
Successful initial results using cannabis terpenes to treat COVID-19

Successful initial results using cannabis terpenes to treat COVID-19

A study to test the efficacy of a unique cannabis terpene formulation for the treatment of viral infections, including COVID-19, has shown early promising...
Cannabinoid therapies aim to address unmet medical needs

Cannabinoid therapies aim to address unmet medical needs

Oxford Cannabinoid Technologies (OCT) has appointed a new Chief Scientific Officer to help deliver cannabinoid therapies for unmet medical needs. Dr Valentino Parravicini, PhD will...
Evidence CBD may reduce cytokine storm and inflammation in COVID-19

Evidence CBD may reduce cytokine storm and inflammation in COVID-19

A new study has revealed early evidence that CBD may help to reduce cytokine storms and excessive lung inflammation in patients with COVID-19. Carried out...
Understanding terpenes with Pure5 Extraction

Understanding terpenes with PURE5 Extraction

The lesser known modulator Current hemp legalisation legislation has sparked a renewed interest in cannabis/hemp compounds for medicinal and recreational uses. At some point in...
Cannabis medicine, education, and policy in Switzerland

Cannabis medicine, education, and policy in Switzerland

Professor Rudolf Brenneisen of the Swiss Society of Cannabis in Medicine tells us about medical cannabis in Switzerland. The Swiss Society of Cannabis in Medicine...
Sanity Group: unlocking the health benefits of cannabinoid medicines

Sanity Group: unlocking the health benefits of cannabinoid medicines

Sanity Group puts people first to improve patient access and drive innovation, and utilises the health benefits of cannabinoid medicines. Putting people first, as well...
Tetra Bio-Pharma: building business on healing potential of cannabinoids

Tetra Bio-Pharma: building business on healing cannabinoid medicines

Canada’s Tetra Bio-Pharma is on a path to become a world leader in the development of cannabinoid-derived medicines. Canada’s Tetra Bio-Pharma is on a path...
cannabinoid

Tilray – Advancing Cannabinoid Science

Tilray’s Medical Advisory Board facilitates ground-breaking advancements in cannabinoid science. Tilray, a Canadian federally-licensed global leader in medical cannabis research and production, is proud to...
PURE5 Extraction: extracting pristine cannabis terpenes

PURE5 Extraction: extracting pristine cannabis terpenes

George Stantchev, PhD, of PURE5 Extraction, explores why it is important to preserve native cannabis terpenes for extraction. Terpenes are aromatic molecules that evaporate easily...
ACI Lays foundation for harmonisation of cannabinoid testing

ACI Lays foundation for harmonisation of cannabinoid testing

The Association for the Cannabinoid Industry (The ACI) has today announced high-level discussions with the Laboratory of Government Chemists (LGC) that will focus on...
MPS disease: the health benefits of cannabinoids to MPS patients

MPS disease: the health benefits of cannabinoids to MPS patients

Over the last few decades, the health benefits of cannabinoids has become an increasingly popular topic, but can this help those with the rare...
An overview of the cannabis drying and curing process

An overview of the cannabis drying and curing process

The curing of farmed cannabis is undertaken for broadly similar reasons to the curing of meats and other perishable foods. By removing destructive bacteria, the...

Pin It on Pinterest